A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy

BACKGROUND: Only a fraction of patients with esophageal squamous cell carcinoma (ESCC) show tumor responses to anti-programmed cell death protein 1 (PD-1) therapy. The predictive value of single biomarkers for prognosis is limited, and a more comprehensive approach that incorporates multiple factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Shoujian, Zhao, Chuanhua, Liu, Rongrui, Wang, Yan, Yang, Qing, Yang, Hua, Xu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272641/
https://www.ncbi.nlm.nih.gov/pubmed/37333902
http://dx.doi.org/10.1177/17588359231174869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272641/
https://www.ncbi.nlm.nih.gov/pubmed/37333902
http://dx.doi.org/10.1177/17588359231174869

Ejemplares similares